Clinical Trials Directory

Trials / Unknown

UnknownNCT02814162

Predictive Values of Serum Adiponectin Levels in Aneurysmal Subarachnoid Hemorrhage.

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Tang-Du Hospital · Academic / Other
Sex
All
Age
16 Years – 90 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the predictive value of serum adiponectin levels in aneurysmal subarachnoid hemorrhage patients.

Detailed description

Adiponectin (APN) is an abundant protein hormone derived from adipose tissue. It has been suggested to exert anti-inflammatory, antiatherogenic, and vascular protective. Subarachnoid hemorrhage (SAH) comprises about 5% of all strokes with high mortality and permanent disability rates. Although many patients survive from the initial hemorrhage or rebleeding, they suffered from long-term delayed neurological deficits (DNDs), including stroke, delayed cerebral ischemia, cognitive and neuropsychological abnormalities that seriously impact overall function and quality of life. Ruptured cerebral aneurysms are the most common cause of SAH. There is growing evidence supporting APN act as a predictive factor for SAH. The observational study will focus on the predictive value of serum adiponectin levels in aneurysmal subarachnoid hemorrhage (aSAH).

Conditions

Timeline

Start date
2016-04-01
Primary completion
2017-06-01
Completion
2017-08-01
First posted
2016-06-27
Last updated
2017-03-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02814162. Inclusion in this directory is not an endorsement.

Predictive Values of Serum Adiponectin Levels in Aneurysmal Subarachnoid Hemorrhage. (NCT02814162) · Clinical Trials Directory